Psychiatry & Neurology, Geriatric Psychiatry · Aiea, HI
NPI
1760414049
Since 2006
Specialty
Psychiatry & Neurology, Geriatric Psychiatry
Code 2084P0805X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
99-128 Aiea Heights Dr Ste 202
Aiea, HI, 96701
Phone (808) 485-5855
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
202 services
Medicare patients, 2024
13
Average age 61
Drug cost, 2024
$1.0M
5,668 prescriptions
Company payments, 2025
$5,015
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joel S Peck was code 90836 (psychotherapy - nongroup), 96 times for 13 patients. In total Joel S Peck billed 202 services in 5 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90836 Psychotherapy - Nongroup | Office | 96 | 13 | $68.14 | $6,541 |
| 99214 Office E&M - Established | Office | 95 | 13 | $97.66 | $9,278 |
By year: 2022 $33K for 401 services; 2023 $28K for 345 services; 2024 $16K for 202 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joel S Peck prescribed most often to Medicare patients was Levetiracetam, with 976 prescriptions and refills. In total Joel S Peck wrote 5,668 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 976 | 1,016 | 67 | $52K |
| Buspirone Hcl Generic | 490 | 514 | 45 | $21K |
| Quetiapine Fumarate Generic | 473 | 483 | 33 | $15K |
| Memantine Hcl Generic | 353 | 367 | 30 | $11K |
| Leucovorin Calcium Generic | 300 | 312 | 28 | $15K |
| Famotidine Generic | 188 | 188 | 16 | $5,250 |
| Gabapentin Generic | 184 | 184 | 12 | $8,090 |
| Lithium Carbonate Generic | 161 | 177 | 17 | $948 |
| Olanzapine Generic | 161 | 163 | Under 11 | $2,624 |
| Propranolol Hcl Generic | 157 | 165 | 16 | $4,625 |
| Lurasidone Hcl Generic | 156 | 156 | Under 11 | $5,398 |
| Rexulti Brexpiprazole | 144 | 144 | 15 | $183K |
| Briviact Brivaracetam | 139 | 139 | Under 11 | $244K |
| Oxcarbazepine Generic | 137 | 147 | 14 | $33K |
| Clozapine Generic | 118 | 118 | Under 11 | $10K |
Brand drugs: 648 claims; generic drugs: 5,020 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joel S Peck $5,015 ($5,015 in general payments such as food, travel and fees) from 12 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $1,148.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 34 | $1,148 |
| Teva Pharmaceuticals USA, Inc. TEVA | 14 | $953 |
| Neurocrine BioSciences, Inc. NBIX | 19 | $765 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $439 |
| Abbvie Inc. ABBV | 4 | $437 |
| Lundbeck LLC | 14 | $356 |
| Alkermes, Inc. ALKS | 9 | $237 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $194 |
| Axsome Therapeutics, Inc. AXSM | 3 | $162 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.